Adel Hassan

Dr. Adel Hassan


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2025 in American Journal of Physiology-Heart and Circulatory Physiology
Verified
Journal Article
Closed access
SLSHIYI LI
SHIYI LI
KNKatherine V. Nordick
Katherine V. Nordick
AEAbdussalam E. Elsenousi
Abdussalam E. Elsenousi
RBRishav Bhattacharya
Rishav Bhattacharya
RKRandall P. Kirby
Randall P. Kirby
Nandan Kumar MondalNandan Kumar Mondal
Nandan Kumar Mondal
The first human heart research explored the effects of ischemia on the myocardial ferroptotic cell death mechanism. Prolonged cold storage increases the susceptibility of DBD hearts to ferroptotic cell death. In contrast, warm ischemic injury appears to be the main factor leading to the vulnerability of DCD heart ferroptosis. Targeting ferroptosis could be beneficial in optimizing cold preservation for DBD hearts. However, for DCD hearts, interventions should focus on the early phase of warm ischemia.

1 January 2026 in American Journal of Physiology-Heart and Circulatory Physiology
Verified
Journal Article
Closed access
SLSHIYI LI
SHIYI LI
RBRishav Bhattacharya
Rishav Bhattacharya
AEAbdussalam E. Elsenousi
Abdussalam E. Elsenousi
KNKatherine V. Nordick
Katherine V. Nordick
AHAdel Hassan
Adel Hassan
Nandan Kumar MondalNandan Kumar Mondal
Nandan Kumar Mondal
This study demonstrates that donor hearts procured after circulatory death (DCD) exhibit early Annexin A1 depletion and activation of the NLRP3/caspase-1/GSDMD-mediated pyroptosis pathway during cold storage—a phenomenon absent in brain-dead (DBD) donors. We establish a direct correlation between warm ischemia time and pyroptotic damage in DCD hearts. These findings highlight Annexin A1 as a crucial mediator of ischemic injury, offering a promising therapeutic target to enhance viability in DCD donor hearts.

Verified
Journal Article
Open access
PDF file
Fabio J. SavorgnanFabio J. Savorgnan
Fabio J. Savorgnan
SFSaul Flores
Saul Flores
JGJulia Garcia-Mancebo
Julia Garcia-Mancebo
AHAdel Hassan
Adel Hassan
Rohit LoombaRohit Loomba
Rohit Loomba
SASebastian Acosta
Sebastian Acosta
Objective: Patients with D-transposition of the great arteries (TGA) often require prostaglandin E1 (PGE) even after balloon atrial septostomy (BAS). This study builds a computer simulation that analyzes whether or not elevated pulmonary vascular resistance (PVR) could explain the profound hypoxemia seen in some patients after PGE discontinuation. Methods: We developed a systems-based mathematical model of TGA incorporating systemic and pulmonary circulations, an atrial septal defect (ASD), and a patent ductus arteriosus (PDA), with bidirectional atrial mixing. The PGE-on pre-BAS state represented restrictive atrial communication, with systemic arterial saturation in the clinically expected 60–70% range. BAS was modeled by reducing ASD resistance and increasing the atrial mixing parameter; PGE withdrawal was modeled by increasing PDA resistance. A reproducible Monte Carlo cohort of 500 virtual patients was generated using independent probability distributions for heart rate, PVR, SVR, ASD resistance, PDA resistance, and atrial mixing. Prespecified sensitivity analyses varied ASD resistance reduction, PDA resistance, and pulmonary and systemic vascular responses to PGE withdrawal. Results: The PGE-on pre-BAS cohort had a median systemic arterial saturation of 64.7% (interquartile range, 59.1–68.8%), which increased to 74.7% (70.6–77.9%) after BAS. Following PGE withdrawal, saturation decreased to 70.9% (66.0–74.4%), while systemic flow increased from 1.83 to 2.04 L/min/m2 and systemic oxygen delivery increased from 271.4 to 283.9 mL O2/min/m2. For the response from PGE-on post-BAS to PGE-off post-BAS, each 1-WU·m2 increase in PVR was associated with a 0.56-percentage-point greater decrease in saturation, a 6.56% smaller increase in systemic flow, a 3.96% greater decrease in effective pulmonary flow, and a 7.87% smaller increase in oxygen delivery (all p < 0.01). Conclusions: In a model representing clinically restrictive pre-BAS atrial communication, PVR strongly modified the response to PGE withdrawal after BAS. Higher PVR was associated with larger decreases in saturation and effective pulmonary flow and smaller improvements in systemic flow and oxygen delivery. Saturation and oxygen delivery may move in opposite directions; therefore, assessment after PGE withdrawal should integrate systemic perfusion rather than rely on saturation alone. These findings are mechanistic and require external clinical validation.